Duodenal Ulcer
📧 Sign up to get email alerts when something new happens for Duodenal Ulcer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-11-10FDA Approved: LANSOPRAZOLE — Original Application (Mylan Pharmaceuticals Inc.)
The FDA approved Mylan Pharmaceuticals Inc.'s Original Application for a generic lansoprazole (Lansoprazole) under ANDA090763. Lansoprazole …
-
FDA approval · 2009-09-21FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole). This action typically updates labeling, manu…
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2) [Phase 2]
Phase 2 clinical trial of ilaprazole for treating duodenal ulcers in Chinese patients has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3) [Phase 3]
Phase 3 trial evaluating ilaprazole for the treatment of duodenal ulcer in Chinese patients has completed.
-
FDA approval · 2009-07-31FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for PREVACID SOLUTAB (lansoprazole) to add the Solutab dosage form to the approved product line. The…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-06-18FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP to update the la…
-
FDA label_change · 2009-05-28FDA Approved: RANITIDINE — Supplemental Application (Pharmaceutical Associates, Inc.)
The FDA approved a supplemental application for ranitidine from Pharmaceutical Associates, Inc., indicating a labeling or related change to …
-
FDA approval · 2009-04-06FDA Approved: RANITIDINE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for ranitidine submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2009-04-02FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole), enabling continued marketing of the product unde…
-
CLINICAL_TRIALS trial_result · 2009-03-03Clinical Trial Update: Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection [Phase 4]
A Phase 4 clinical trial assessed whether a patient's metabolic rate affects the eradication of Helicobacter pylori with omeprazole in duode…
-
FDA approval · 2009-02-27FDA Approved: CIMETIDINE 200 ACID REDUCER — Supplemental Application (Walgreen Company)
FDA approved a supplemental application to approve Walgreens' Cimetidine 200 Acid Reducer as a generic cimetidine product.
-
FDA approval · 2009-01-21FDA Approved: OMEPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for omeprazole filed by Quallent Pharmaceuticals Health LLC under an ANDA.
-
FDA approval · 2009-01-21FDA Approved: OMEPRAZOLE — Original Application (Sandoz Inc)
FDA approved the original application for omeprazole from Sandoz Inc, authorizing a generic version of this proton pump inhibitor.
-
FDA approval · 2008-12-01FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) by Covis Pharma US, Inc. to update and/or expand the product lab…
-
FDA approval · 2008-11-24FDA Approved: ACID CONTROLLER — Supplemental Application (H E B)
FDA approved a supplemental application for ACID CONTROLLER (famotidine) from H E B. The approval expands the product's labeling/indications…
-
CLINICAL_TRIALS trial_result · 2008-10-23Clinical Trial Update: Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers [Phase 4]
A Phase 4 trial evaluating whether naproxen, aspirin, celecoxib, or clopidogrel affect healing of gastric and duodenal ulcers; the study is …
-
FDA approval · 2008-09-12FDA Approved: SUCRALFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for sucralfate by Teva Pharmaceuticals USA, Inc., marking an approved modification to the generic pr…
-
FDA approval · 2008-06-30FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2008-06-25FDA Approved: FAMOTIDINE — Original Application (Mylan Institutional LLC)
The FDA approved a generic famotidine product from Mylan Institutional LLC under an original ANDA.
-
FDA approval · 2008-06-03FDA Approved: FAMOTIDINE — Supplemental Application (Sagent Pharmaceuticals)
The FDA approved Sagent Pharmaceuticals' supplemental application for famotidine under an existing ANDA, updating the product's approved lab…
-
FDA approval · 2008-06-03FDA Approved: FAMOTIDINE — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for famotidine from Sagent Pharmaceuticals, confirming the generic product under ANDA075651.
-
FDA approval · 2008-05-20FDA Approved: FAMOTIDINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for famotidine (Hikma Pharmaceuticals USA Inc.). The approval updates the labeling to reflect additi…
-
FDA approval · 2008-04-21FDA Approved: PREVACID — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID (lansoprazole) filed by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2008-04-21FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approves a supplemental application for PREVACID SOLUTAB (lansoprazole) filed by Takeda Pharmaceuticals America, expanding the product's…
-
CLINICAL_TRIALS trial_result · 2008-03-24Clinical Trial Update: Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers [Phase 1]
Phase 1 dose-escalation study of S-Tenatoprazole-Na (30, 60, 90, 120 mg) in healthy volunteers to characterize dose-related pharmacodynamics…